RonanRx 进入 YC 时承诺提供个性化的 GLP-1s；服务目前仅覆盖德克萨斯州
Lloyd Armbrust 和 Emily Colman 正在将由医生设定的剂量与一家独立的调配药房相配合，同时为更广泛的全国性扩建进行营销。
By Ryan Merket · Published
Primary source: Y Combinator
为何重要
RonanRx 正在测试 AI 指导的、针对患者的个性化处方是否能在监管机构限制品牌药标准化复制品时，支撑起一个持久的配制型 GLP-1 业务。
On August 4th, Lloyd Armbrust and Emily Colman launched RonanRx, an AI-assisted GLP-1 care platform in Y Combinator's Summer 2026 batch that proposes individualized dosing plans for physicians and coordinates fulfillment through a compounding pharmacy.…
When you purchase through links in our articles, we may earn a small commission. This doesn’t affect our editorial independence.